Time matters for patients with cancer. Lifyorli plus nab-paclitaxel for platinum-resistant ovarian cancer may help women live longer than with chemotherapy alone.

LIFYORLI is an oral medication designed to help chemotherapy work better. By inhibiting cortisol activity in cancer and immune cells, it makes nab-paclitaxel, a chemotherapy, more effective and may indirectly activate the immune system. This helps support the immune system in fighting platinum-resistant ovarian cancer.

Role: Designer
Agency: PropelHealth